Skip to Content

93 7771 (Risedronate Sodium 150 mg)

Pill with imprint 93 7771 is White, Round and has been identified as Risedronate Sodium 150 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Risedronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7771

Risedronate Sodium

Imprint
93 7771
Strength
150 mg
Color
White
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-7771
Inactive Ingredients
silicon dioxide, corn starch, lactose monohydrate, magnesium stearate, polyethylene glycol 3350, sodium stearyl fumarate, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.